Stock DUL ALNYLAM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Alnylam Pharmaceuticals, Inc. Börse Stuttgart

Equities

DUL

US02043Q1076

Market Closed - Börse Stuttgart
Other stock markets
 07:44:12 28/06/2024 pm IST 		5-day change 1st Jan Change
227.6 EUR -1.47% Intraday chart for Alnylam Pharmaceuticals, Inc. +55.68% +29.61%
28/06 UBS Adjusts Price Target on Alnylam Pharmaceuticals to $288 From $253, Maintains Buy Rating MT
27/06 Stifel Adjusts Price Target on Alnylam Pharmaceuticals to $295 From $215, Maintains Buy Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. DUL Stock
  5. Revisions Alnylam Pharmaceuticals, Inc.